Thyroid cancer proteomics

Show results for

Proteomics (89)
Unknown (87)
Transcriptomics (4)
Models (1)
Genomics (1)

Organisms

Chlamydomonas reinhardtii (44)
Pseudomonas canadensis (44)
Marchantia polymorpha subsp. ruderalis (44)
Methylocystis sp. (44)
Exiguobacterium sp. SH31 (44)
Porites pukoensis (44)
Bothrops insularis (44)
Bothrops jararaca (44)
Bothrops jararacussu (44)
Bothrops cotiara (44)
Dinosauria (44)
Trypanosoma vivax Y486 (44)
Streptomyces coelicolor (44)
Pseudomonas taiwanensis (44)
Burkholderia ubonensis MSMB22 (44)
Pseudomonas aeruginosa PA103 (44)
Artibeus jamaicensis (44)
Morchella importuna (44)
Clostridium autoethanogenum (44)
Microbacterium ginsengisoli (44)
Streptomyces sp. A494 Ydz-AH (44)
Shewanella oneidensis MR-1 (44)
Leucocoprinus gongylophorus (44)
Bothrops brazili (44)
Ixodes scapularis (44)
Homo sapiens (28)
Mus musculus (4)
Cancer (1)
Rattus norvegicus (1)
cellular organisms (1)

Organisms

Homo sapiens (1)

Repository

pride (44)
iProX (25)
MassIVE (10)
biostudies-arrayexpress (6)
PAXDB (5)
jPOST (2)
BioModels (1)
PanoramaPublic (1)
ENA (1)

Tissue

Thyroid gland (14)
Cell culture (7)
Thyroid nodule (5)
Blood plasma (5)
Lung (4)
Heart (4)
Kidney (4)
Epithelial cell (4)
Bladder (3)
Lymph node (3)
Skin (3)
Gall bladder (3)
Pancreas (3)
Testis (3)
Adrenal gland (3)
Spleen (3)
Liver (3)
Thyroid follicular cell (2)
Tongue (2)
Aorta (2)
Small intestine (2)
Cerebellum (2)
Bone marrow (2)
Muscle (2)
Blood cell (2)
Colon (2)
Stomach (2)
Breast (2)
Prostate gland (2)
Uterus (2)

Disease

Thyroid cancer (10)
Breast cancer (2)
Disease free (2)
Thyroid gland anaplastic carcinoma (1)
Papillary thyroid carcinoma (1)
Thyroid gland follicular carcinoma (1)
Lung squamous cell carcinoma (1)
Gastrointestinal carcinoma (1)
Stomach carcinoma in situ (1)
Chronic bronchitis (1)
Non-small cell lung carcinoma (1)
Skin melanoma (1)
Diffuse gastric cancer (1)
Urinary bladder cancer (1)
Cancer (1)

Technology Type

Mass Spectrometry (44)
Shotgun proteomics (25)
Gel-based experiment (4)
Bottom-up proteomics (4)
SWATH MS (3)
HDMSE (2)
Top-down proteomics (2)
Data-dependent acquisition (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Data-independent acquisition (2)
SRM/MRM (1)

Instrument Platform

LTQ Orbitrap Elite (3)
Orbitrap Fusion (3)
Illumina HiSeq 2500 (2)
Q Exactive (2)
Synapt MS (1)
SolariX (1)
TripleTOF 5600 (1)
Q Exactive HF (1)
Orbitrap Fusion Lumos (1)

Publication Date

2024 (11)
2022 (11)
2025 (10)
2023 (10)
2020 (7)
2015 (4)
2026 (4)
2021 (4)
2017 (3)
2019 (3)
2018 (3)
2016 (2)
2012 (2)
2014 (2)
2013 (1)
2008 (1)

UNIPROT ID/AC

Q9HP76_HALSA (5)
G3P_HALSA (5)
RL37_HALSA (5)
Q9HS54_HALSA (5)
Q9HSD9_HALSA (5)
Q9HRJ1_HALSA (5)
Q9HPR4_HALSA (5)
Q9HNA0_HALSA (5)
Q9HRC9_HALSA (5)
Q9HMT6_HALSA (5)
GCSPA_HALSA (5)
Q9HRY6_HALSA (5)
Q9HPM3_HALSA (5)
HIS6_HALSA (5)
GCH32_HALSA (5)
Q9HPW6_HALSA (5)
Q9HQD0_HALSA (5)
Q9HM98_HALSA (5)
VATB_HALSA (5)
RS5_HALSA (5)
Q9HSD8_HALSA (5)
Q9HQ85_HALSA (5)
Q9HMT7_HALSA (5)
Q9HM99_HALSA (5)
Q9HPM2_HALSA (5)
Q9HSF0_HALSA (5)
CARB_HALSA (5)
Q9HPH2_HALSA (5)
GPMI_HALSA (5)
Q9HNU5_HALSA (5)

CHEBI ID

CHEBI:15627 (1)
CHEBI:28922 (1)
CHEBI:28852 (1)
CHEBI:34939 (1)
CHEBI:27696 (1)
CHEBI:27555 (1)
CHEBI:15546 (1)
CHEBI:28099 (1)
CHEBI:27624 (1)
CHEBI:17606 (1)
CHEBI:16874 (1)
CHEBI:16565 (1)
CHEBI:9533 (1)
CHEBI:36528 (1)
CHEBI:15958 (1)
CHEBI:17927 (1)
CHEBI:28101 (1)
CHEBI:7101 (1)
CHEBI:3110 (1)
CHEBI:16480 (1)
CHEBI:28743 (1)
CHEBI:27847 (1)
CHEBI:15768 (1)
CHEBI:34306 (1)
CHEBI:28865 (1)
CHEBI:35420 (1)
CHEBI:16382 (1)
CHEBI:18318 (1)
CHEBI:37998 (1)
CHEBI:17687 (1)

IsPrivate

False (1)

Model Flag

Non Kinetic (1)

First Public Date

2024 (1)

Modification

3'' (1)

Study type

Transcription profiling by array (2)
Proteomic profiling by array (2)
RNA-seq of coding RNA (2)

Release Date

2025 (14)
2022 (13)
2023 (10)
2024 (9)
2018 (7)
2017 (6)
2012 (5)
2021 (5)
2020 (5)
2016 (4)
2015 (4)
2019 (3)
2014 (2)
2011 (2)
2009 (2)
2026 (1)
2010 (1)

Lab affiliation

Department of Peptide-based Immunotherapy, University and University Hospital Tuebingen, Germany (1)
Departments of Medical Radiation Sciences and Oncology Institute of Clinical Sciences Sahlgrenska Center for Cancer Research University of Gothenburg Sweden (1)
Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35042 Rennes, France (1)
Department of Immunology, Interfaculty Institute for Cell Biology, Eberhard Karls University Tübingen (1)
Department of Thyroid and Breast Surgery, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, jing zhang lab,wuhan university, wuhan china (1)
NOVA Medical School, Faculdade de Ciências Médicas (NMS|FCM), Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal (1)
Department of Gametes and Embryo Biology, Institute of Animal Reproduction and Food Research Polish Academy of Sciences (1)
Dalian Institute of Chemcial and Physics, China (1)
Graduate Institute of Biomedical Sciences, department of Cell and Molecular Biology, College of Medicine, and Molecular Medicine Research Center, Chang Gung University, Taoyuan 33302, Taiwan. Liver Research Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan 33302, Taiwan. (1)
Sichuan University, Westchina Hospital (1)
Department of Hernia and Abdominal Wall Surgery, General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China. (1)
Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising GERMANY (1)
Department of Medicine (GI Oncology), UCSF, United States (1)
Macquarie University Australian Proteome Analysis Facility (APAF) Sydney, Australia (1)
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, National Key Laboratory of Medical Molecular Biology & Department of Immunology, No 5 Dongdan Santiao, Dongcheng district, Beijing 100005, China. (1)
School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China (1)
CEINGE, Biotecnologie Avanzate, F. Salvatore, Naples (1)
General Manager of PROMEC, NTNU, Norway (1)
Dalian Institute of Chemical and Physics, Chinese Academy of Sciences (1)
Center for Translational and Clinical Research, Department of Proteomics, School of Medicine, University of Zagreb, Zagreb, Croatia (1)
Mass Spectrometry & Proteomics CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Vienna, Austria (1)
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, National Key Laboratory of Medical Molecular Biology & Department of Immunology, No 5 Dongdan Santiao, Dongcheng district, Beijing 100005, China (1)
Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China. Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China. Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China. (1)
università degli studi di Milano, medicina veterinaria, DIMEVET (1)
Proteomics Service CIC bioGUNE, Build. 800 Bizkaia Tech. Derio 48160 Spain (1)
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch Gliwice, Poland (1)
Department of Genetics, Stanford University (1)
Department of Pathology, Faculty of Medicine, Chulalongkorn University (1)
CNIO (1)
Department of Thyroid and Breast Surgery, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China (1)

Previous page
1 / 19
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 19
Next page

Sort by:

Relevance

Page size

Shotgun proteomics of thyroid carcinoma exosomes: insight into the role of exosomal proteins in carcinogenesis and thyroid homeostasis

The transport of molecules via exosomes is one of the factors involved in cancer development, and transferred molecules can serve as specific tumor biomarkers. The aim of the study was the LC MS/MS proteomic analysis of exosomes released by FTC and 8305C thyroid cancer cell lines, and reference Nthy...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2023-10-19 | MSV000093152 | MassIVE

Comparative proteomic profiling of ectosomes derived from thyroid carcinoma and normal thyroid cells uncovers multiple proteins with functional implications in cancer

Proteins carried by tumor-derived ectosomes play an important role in cancer progression and are considered promising diagnostic markers. In the present study a shotgun nanoLC-MS/MS proteomic approach was applied to profile and compare the protein content of ectosomes released in vitro by normal hum...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2022-02-17 | MSV000088850 | MassIVE

Papillary thyroid cancer proteomics

Label-free proteomics profiling of 37 paired tumor-normal tissues of papillary thyroid cancer

ORGANISM(S): Homo sapiens (Human)

2024-02-08 | PXD044900 | Pride

Proteomics of thyroid tumours - Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy

Although most thyroid tumours are benign, thyroid cancer represents the most common malignancy of the endocrine system, comprising mainly follicular and papillary thyroid carcinomas (FTC and PTC, respectively). Previous studies have shed some light on the molecular pathogenesis of thyroid cancer but...

ORGANISM(S): Homo sapiens (Human)

2017-05-03 | PXD002732 | Pride

Swath Thyroid cancer proteomics

Multiomics analysis of Papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCdelta for tumorigenesis

Papillary thyroid carcinoma (PTC) is one of the most common forms of thyroid cancer with a cure rate of over 90% after surgery. However, aggressive forms may still occur, and personalized therapeutic strategies are increasingly required. We subjected patient materials from a cohort of patients whose...

ORGANISM(S): Homo Sapiens (human)

2023-02-22 | PXD034229 | JPOST Repository

Integrative Proteogenomic Characterization Reveals Therapeutic Targets in Poorly Differentiated and Anaplastic Thyroid Cancers

In our study, we constructed a multicenter thyroid-cancer cohort consisting of 467 formalin-fixed paraffin-embedded (FFPE) samples, among which WES, proteome, and phosphorylated proteome analysis were conducted. Thyroid tumors consisted of 124 ATC samples, 47 PDTC samples and 177 PTC samples (includ...

ORGANISM(S): Homo Sapiens

2025-03-16 | PXD054521 |

Quantitative proteomics analysis of medullary thyroid carcinoma

Medullary thyroid cancer (MTC) accounts for less than 5% of all thyroid cancers, and it is a rare neuroendocrine tumor which derives from calcitonin-secreting thyroid C cells.Given the underlying mechanism involved in MTC remain unclear, the development and the specific pathways of MTC require furth...

ORGANISM(S): Homo sapiens (Human)

2020-05-26 | PXD005898 | Pride

Proteomics Syt1 Medullary thyroid carcinoma Ecm remolding

Multiomic approaches for thyroid cancer diagnosis

Thyroid cancer is a common endocrine malignancy; however, its diagnosis is not straightforward. The current gold standard for diagnosing thyroid cancer is fine needle aspiration biopsy (FNAB), but when cytological analysis does not provide viable results or samples belong to less defined categories ...

ORGANISM(S): Homo sapiens (Human)

2023-10-24 | PXD035583 | Pride

Mixomics Tissue Swath-ms Proteomics Thyroid cancer Biomarkers

Proteomics analysis of extracellular vesicles from thyroid tumours

Extracellular vesicles (EVs) participate in cell-stroma crosstalk within tumor microenvironment (TME) and Fb are key elements that contribute to tumor promotion. In thyroid cancer, the most prevalent endocrine malignancy, the relevance of Fb in the TME and EVs is beginning to be deciphered. Using an...

ORGANISM(S): Homo sapiens (Human)

2022-08-02 | PXD028081 | Pride

Thyroid tumour Extracellular vesicles Tumor-stroma crosstalk Fibroblasts

Papillary thyroid cancer phosphorylated proteomics

Phosphorylated proteomics profiling were performed on 37 paired tumor-normal tissues of human papillary thyroid cancer

ORGANISM(S): Homo sapiens (Human)

2024-02-08 | PXD045017 | Pride

Papillary thyroid cancer Human Phosphorylated proteomics

Previous page
1 / 19
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 19
Next page

Sort by:

Relevance

Page size

182 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

IsPrivate

Model Flag

First Public Date

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets